Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2016151500) PARTICLES OF N-(5-CYANO-4-((2-METHOXYETHYL)AMINO)PYRIDIN-2-YL)-7-FORMYL-6-((4-METHYL-2- OXOPIPERAZIN-1-YL)METHYL)-3,4-DIHYDRO-1,8-NAPHTHYRIDINE-1(2H)-CARBOXAMIDE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2016/151500 International Application No.: PCT/IB2016/051633
Publication Date: 29.09.2016 International Filing Date: 23.03.2016
IPC:
C07D 471/04 (2006.01) ,A61K 31/4375 (2006.01) ,A61P 35/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
471
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
4353
ortho- or peri-condensed with heterocyclic ring systems
4375
the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
Applicants:
NOVARTIS AG [CH/CH]; Lichtstrasse 35 4056 Basel, CH (AllExceptUS)
BUSCHMANN, Nicole [DE/CH]; CH (US)
FAIRHURST, Robin Alec [GB/CH]; CH (US)
FURET, Pascal [FR/CH]; CH (US)
KNOEPFEL, Thomas [CH/CH]; CH (US)
LEBLANC, Catherine [FR/CH]; CH (US)
MAH, Robert [CA/CH]; CH (US)
MALLET, Franck [FR/CH]; CH (US)
MARTZ, Julie [FR/CH]; CH (US)
LIAO, Lv [CN/CN]; CN (US)
XIONG, Jing [CN/CN]; CN (US)
HAN, Bo [CN/CN]; CN (US)
WANG, Can [CN/CN]; CN (US)
ZHAO, Xianglin [CN/CN]; CN (US)
Inventors:
BUSCHMANN, Nicole; CH
FAIRHURST, Robin Alec; CH
FURET, Pascal; CH
KNOEPFEL, Thomas; CH
LEBLANC, Catherine; CH
MAH, Robert; CH
MALLET, Franck; CH
MARTZ, Julie; CH
LIAO, Lv; CN
XIONG, Jing; CN
HAN, Bo; CN
WANG, Can; CN
ZHAO, Xianglin; CN
Agent:
NOVARTIS AG; Lichtstrasse 35 4056 Basel, CH
Priority Data:
PCT/CN2015/00020225.03.2015CN
Title (EN) PARTICLES OF N-(5-CYANO-4-((2-METHOXYETHYL)AMINO)PYRIDIN-2-YL)-7-FORMYL-6-((4-METHYL-2- OXOPIPERAZIN-1-YL)METHYL)-3,4-DIHYDRO-1,8-NAPHTHYRIDINE-1(2H)-CARBOXAMIDE
(FR) PARTICULES DE N-(5-CYANO-4-((2-MÉTHOXYÉTHYL)AMINO)PYRIDIN-2-YL)-7-FORMYL-6-((4-MÉTHYL-2-OXOPIPÉRAZIN-1-YL)MÉTHYL)-3,4-DIHYDRO-1,8-NAPHTHYRIDINE-1(2H)-CARBOXAMIDE
Abstract:
(EN) The present invention relates to particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7- formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide, to a process of making said particles, to pharmaceutical compositions comprising said particles and to method of treating cancers using said pharmaceutical compositions.
(FR) Cette invention concerne des particules de N-(5-cyano-4-((2-méthoxyéthyl)amino)pyridin-2-yl)-7-formyl-6-((4-méthyl-2-oxopipérazin-1-yl)méthyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide, un procédé de fabrication desdites particules, des compositions pharmaceutiques les contenant et une méthode destinée à traiter les cancers à l'aide desdites compositions pharmaceutiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
AU2016238437CN107406448CA2977326KR1020170129758EP3274349MX2017012293
JP2018509446BR112017016991RU2017133243